Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a dynamic framework for rapid decision-making

Vicki Osborne, Miranda Davies, Sandeep Dhanda, Debabrata Roy, Samantha Lane, Alison Evans, Saad Shakir
doi: https://doi.org/10.1101/2020.05.07.20093989

Data Availability

Data used in this analysis are available from the references supplied.

Back to top
Posted June 09, 2020.
Download PDF
Data/Code
Email
Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a dynamic framework for rapid decision-making
Vicki Osborne, Miranda Davies, Sandeep Dhanda, Debabrata Roy, Samantha Lane, Alison Evans, Saad Shakir
medRxiv 2020.05.07.20093989; doi: https://doi.org/10.1101/2020.05.07.20093989
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area